Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
HCC1143 | Senexin B | 10.0 | 0.4497 | 0.02714 |
HCC1143 | Senexin B | 10.0 | 0.4707 | 0.02508 |
HCC1143 | Senexin B | 10.0 | 0.4142 | 0.01380 |
HCC1395 | MK 1775 | 0.001 | 0.7320 | 0.01267 |
HCC1395 | MK 1775 | 0.001 | 0.7498 | -0.00647 |
HCC1395 | MK 1775 | 0.001 | 0.7260 | 0.00651 |
HCC1395 | MK 1775 | 0.00316227766017 | 0.7409 | 0.00405 |
HCC1395 | MK 1775 | 0.00316227766017 | 0.4951 | 0.02144 |
HCC1395 | MK 1775 | 0.00316227766017 | 0.6579 | -0.00433 |
HCC1395 | MK 1775 | 0.01 | 0.5403 | 0.02877 |
HCC1395 | MK 1775 | 0.01 | 0.3764 | 0.02098 |
HCC1395 | MK 1775 | 0.01 | 0.4385 | 0.01902 |
HCC1395 | MK 1775 | 0.0316227766017 | 0.1126 | 0.08056 |
HCC1395 | MK 1775 | 0.0316227766017 | 0.1983 | 0.03043 |
HCC1395 | MK 1775 | 0.0316227766017 | 0.2748 | 0.04395 |
HCC1395 | MK 1775 | 0.1 | 0.0306 | 0.08133 |
HCC1395 | MK 1775 | 0.1 | 0.0196 | 0.04530 |
HCC1395 | MK 1775 | 0.1 | 0.1504 | 0.11243 |
HCC1395 | MK 1775 | 0.316227766017 | -0.0994 | 0.02870 |
HCC1395 | MK 1775 | 0.316227766017 | 0.0348 | 0.04120 |
HCC1395 | MK 1775 | 0.316227766017 | 0.0917 | 0.06117 |
HCC1395 | MK 1775 | 1.0 | -0.1990 | 0.09496 |
HCC1395 | MK 1775 | 1.0 | -0.1829 | 0.07922 |
HCC1395 | MK 1775 | 1.0 | -0.0093 | 0.05442 |
HCC1395 | MK 1775 | 3.16227766017 | -0.1856 | 0.09273 |